Men with recurrent or advanced prostate cancer may be put on hormone therapy to block testosterone production in an effort to halt or slow the growth of the tumor.…

The men most at risk for aggressive prostate cancer - black men with a family history - are the least likely to…

About one third of prostate cancer patients in the United States use some type of complementary or alternative medicine, a large national study shows.

Its important for patients to tell their…

Men who’ve been treated for prostate cancer and are taking one of the popular cholesterol-lowering ‘statin’ drugs (Lipitor and Zocor are examples) may be on to a good thing.

Statins appear to…

Two variations in the gene for insulin-like growth factor I (IGF-1) are linked to an increased risk of prostate cancer, according to research performed by scientists…

Rutgers researchers have found that the curry spice turmeric holds real potential for the treatment and prevention of prostate cancer, particularly when combined with certain…

In the latest study to question the value of prostate cancer screening, researchers have shown that evaluation with prostate-specific antigen (PSA) testing or digital rectal examination does not reduce mortality.

Screening men for prostate cancer may not reduce their risk for dying, according to a new study in the January 9 issue of Archives of Internal…

For men undergoing prostate removal for prostate cancer, biofeedback training before the surgery reduces the duration and severity of urinary incontinence after the procedure, according to a report in The…

Even a few counseling sessions on sex after prostate cancer can help improve a couple’s sex life, at least in the short term, research hints.

Researchers found that among 84…

A high lean body mass - calculated using an equation to determine body mass minus the fat - may lower the risk of prostate cancer, a new study indicates.

Researchers have developed a new line of prostate cancer cells that they hope will provide a better model to study the disease.

This new cancer-cell line has already…

University of North Carolina at Chapel Hill scientists have identified a molecule that stimulates the aggressive growth of prostate cancer.

The molecule, Ack1, a member of the growth-promoting…

Men with high-risk prostate cancer fare better when they are treated with at least 12 months of hormone reduction therapy rather than with a shorter duration of treatment, new research…

Even if patients have relatively low prostate specific antigen (PSA) levels, a biological marker for the disease, abnormalities detected by digital rectal examination (DRE) can help identify prostate cancer,…

An olive-oil based herbal extract preparation called Zyflamend suppresses the growth of prostate cancer cells and induces prostate cancer cells to self-destruct, according to a new study.

Zyflamend has the ability,…

In men with prostate cancer, a small prostate size is associated with higher grade, more advanced prostate cancer, and a greater risk of disease progression, according to a new report.

“Prostate…

Middle-aged men with an initial prostate specific antigen (PSA) level of less than 1 can safely wait for 3 years before repeating the PSA test, a study suggests, while those with…